Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hodgkin Disease × Triptorelin Pamoate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 43 Breast Neoplasms 10 Polycystic Ovary Syndrome 8 Infertility 6 Ovarian Hyperstimulation Syndrome 3 Lymphoma 3 Sarcoma, Ewing 2 Sarcoma 2 Osteosarcoma 2 Neoplasms 2 Uterine Anomalies 1 The Neoadjuvant Therapy 1 Sleep Wake Disorders 1 Salpingitis 1 Salivary Gland Neoplasms 1 Prostate Adenocarcinoma 1 Primary Ovarian Insufficiency 1 Pregnancy, Ectopic 1 Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel 1 Myofibroma 1 Metabolic Syndrome 1 Leiomyoma 1 Infertility, Female 1 Hypogonadism 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1 Fatty Liver 1 Fatigue 1 Endometritis 1 Endometriosis 1

Interventions

Cyclophosphamide 172 Etoposide 97 fludarabine phosphate 95 Peripheral Blood Stem Cell Transplantation 82 Filgrastim 77 Mycophenolic Acid 73 Doxorubicin 72 Melphalan 69 Whole-Body Irradiation 68 Radiotherapy 65 Brentuximab Vedotin 64 fludarabine 60 Tacrolimus 60 Busulfan 59 Cyclosporine 54 Vinblastine 53 Rituximab 52 Dacarbazine 46 Bleomycin 45 Granulocyte Colony-Stimulating Factor 44 Gemcitabine 42 Vincristine 40 Prednisone 40 Antilymphocyte Serum 40 Cytarabine 39 Methotrexate 35 Carmustine 33 Nivolumab 32 pembrolizumab 31 Sirolimus 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01764230 2013-01-09

OVARONKO

Masaryk University

Phase NA Completed

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡